Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate
- 1 September 1998
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 70 (3) , 518-522
- https://doi.org/10.1016/s0015-0282(98)00213-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of lifeFertility and Sterility, 1998
- Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancyThe Lancet, 1997
- Laparoscopic management of ectopic pregnancyCurrent Opinion in Obstetrics and Gynecology, 1995
- Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials?Journal of Clinical Epidemiology, 1994
- Methotrexate treatment of ectopic pregnancyActa Obstetricia et Gynecologica Scandinavica, 1994
- Test-Retest Reliabilities of Two Treatment-preference Instruments in Measuring UtilitiesMedical Decision Making, 1993
- Adhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomyFertility and Sterility, 1991
- Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participationSocial Science & Medicine, 1991
- Whose Utilities for Decision Analysis?Medical Decision Making, 1990
- Outpatient chemotherapy of unruptured ectopic pregnancyFertility and Sterility, 1989